The CCT/TRiC chaperonin is required for maturation of sphingosine kinase 1  by Zebol, Julia R. et al.
TJ
P
a
b
c
d
a
A
R
R
A
A
K
C
C
T
P
S
1
t
a
s
(
o
t
a
a
T
n
B
1
dThe International Journal of Biochemistry & Cell Biology 41 (2009) 822–827
Contents lists available at ScienceDirect
The International Journal of Biochemistry
& Cell Biology
journa l homepage: www.e lsev ier .com/ locate /b ioce l
he CCT/TRiC chaperonin is required for maturation of sphingosine kinase 1
ulia R. Zebola,1, Niamh M. Hewitta,1, Paul A.B. Moretti a, Helen E. Lynna, Julie A. Lakeb,
eng Lib, Mathew A. Vadasa,c,2, Binks W. Wattenberga,3, Stuart M. Pitsona,d,∗
Hanson Institute, Division of Human Immunology, Institute of Medical and Veterinary Science, Frome Road, Adelaide, SA 5000, Australia
Infectious Diseases Laboratories, Institute for Medical and Veterinary Science, Frome Road, Adelaide, SA 5000, Australia
School of Medicine, University of Adelaide, Adelaide, SA 5005, Australia
School of Molecular and Biomedical Science, University of Adelaide, Adelaide, SA 5005, Australia
r t i c l e i n f o
rticle history:
eceived 11 July 2008
eceived in revised form 7 August 2008
ccepted 11 August 2008
vailable online 14 August 2008
eywords:
haperonin
CT
RiC
rotein folding
a b s t r a c t
Sphingosine kinase 1 (SK1) catalyses the generation of sphingosine 1-phosphate (S1P), a bioactive
phospholipid that inﬂuences a diverse range of cellular processes, including proliferation, survival, adhe-
sion, migration, morphogenesis and differentiation. SK1 is controlled by various mechanisms, including
transcriptional regulation, and post-translational activation by phosphorylation and protein–protein
interactions which can regulate both the activity and localisation of this enzyme. To gain a better under-
standing of the regulatory mechanisms controlling SK1 activity and function we performed a yeast
two-hybrid screen to identify SK1-interacting proteins. Using this approach we identiﬁed that SK1 inter-
acts with subunit 7 () of cytosolic chaperonin CCT (chaperonin containing t-complex polypeptide, also
called TRiC for TCP-1 ring complex), a hexadecameric chaperonin that binds unfolded polypeptides and
mediates their folding and release in an ATP-dependent manner. Further analysis of the SK1–CCT inter-phingosine kinase action demonstrated that other CCT/TRiC subunits also associated with SK1 in HEK293T cell lysates in
an ATP-sensitive manner, suggesting that the intact, functional, multimeric CCT/TRiC complex associated
with SK1. Furthermore, pulse-chase studies indicated that CCT/TRiC binds speciﬁcally to newly translated
SK1. Finally, depletion of functional CCT/TRiC through the use of RNA interference in HeLa cells or temper-
ature sensitive CCT yeast mutants reduced cellular SK1 activity. Thus, combined this data suggests that
SK1 is a CCT/TRiC substrate, and that this chaperonin facilitates folding of newly translated SK1 into its
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cmature active form.
. Introduction
Sphingosine kinases (SKs) catalyse the generation of the bioac-
ivephospholipid sphingosine1-phosphate (S1P),which inﬂuences
diverse range of cellular processes, including proliferation,
urvival, adhesion, migration, morphogenesis and differentiation
Pébay et al., 2007; Hannun and Obeid, 2008). Many of the actions
f S1P aremediated through S1P-speciﬁcG-protein-coupled recep-
ors ofwhich ﬁve have been identiﬁed. These cell-surface receptors
re differentially expressed and linked to different G proteins,
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llowing S1P to elicit a variety of somewhat cell-speciﬁc responses
hrough the activation of classic Gi, Gq and G12 signalling path-
ays (Rosen and Goetzl, 2005). In addition to this cell surface
eceptor-mediated signalling, S1P also appears to have intracellu-
ar second messenger functions, especially in calcium homeostasis,
ell growth, and suppression of apoptosis (Spiegel and Milstien,
003).
Cellular levels of S1P are largely regulated by SKs, of which
wo mammalian isoforms have been described (SK1 and SK2).
umerous studies have implicated SK1, but not SK2, in enhanc-
ng cell proliferation and survival, with forced overexpression of
his enzyme also inducing NIH3T3 ﬁbroblasts to acquire the trans-
ormed phenotype and the ability to form tumours in mice (Xia et
l., 2000). More recently, evidence has emerged in support of a role
or elevated cellular SK1 levels in the formation and/or progression
Open access under CC BY-NC-ND license. f naturally occurring tumours, leading to considerable interest in
K1 as a target for anticancer therapies (Cuvillier, 2007).
SK1 is regulated by various mechanisms. A number of cellular
timuli can induce upregulation of SK1 expression, including estro-
en (Sukocheva et al., 2003), epidermal growth factor (Döll et al.,
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005), transforming growth factor- (Yamanaka et al., 2004) and
istamine (Huwiler et al., 2006). Post-translational regulation of
K1 also occurs via phosphorylation at Ser225 (in human SK1). This
hosphorylation not only directly enhances the catalytic activity of
K1, but is also required for its translocation from the cytoplasm to
he plasma membrane which is important for its signalling func-
ions (Pitson et al., 2003; Pitson et al., 2005). Furthermore, the
ctivity and subcellular localisation of SK1 also appears to be reg-
lated by a variety of interacting proteins, including eukaryotic
longation factor1A (eEF1A) (Leclercqet al., 2008), TRAF2 (Xia et al.,
002), SK1-interacting protein (SKIP) (Lacana et al., 2002), PECAM-
(Fukuda et al., 2004), and Lyn and Fyn tyrosine kinases (Olivera
t al., 2006; Sun et al., 2006). The molecular mechanisms whereby
hese protein–protein interactions regulate SK1, however, are yet
o be determined.
To gain a better understanding of the regulatory mechanisms
ontrolling SK1 activity and function we have performed a yeast
wo-hybrid screen to identify SK1-interactingproteins. In this study
e report that the cytosolic chaperonin CCT/TRiC (CCT for chap-
ronin containing t-complex polypeptide, but also called TRiC for
CP-1 ring complex) interactswith SK1. Furthermore,we show that
CT/TRiC binds speciﬁcally to newly translated SK1 and mediates
ts folding into itsmature active form. Thus, this represents another
evel of regulation of cellular SK1 levels and activity.
. Materials and methods
.1. Yeast two-hybrid screen
Yeast two-hybrid screening was performed using the Match-
aker Gal4 Two-Hybrid System 3 (Clontech) according to the
anufacturer’s instructions. Full-length human SK1 cDNA (Pitson
t al., 2000a) was cloned into pGBKT7 (Clontech) in-frame with
he Gal4 DNA-binding domain. This bait construct was then trans-
ormed into Saccharomyces cerevisiaeAH107 togetherwith ahuman
eukocyte cDNA library in pACT2 (Clontech). A total of 1×106 trans-
ormantswere screened for growth on yeast synthetic dropout (SD)
edium lacking tryptophan, leucine and histidine. Total plasmid
NA was then isolated from surviving His+ colonies, pACT2 plas-
ids ampliﬁed in Escherichia coli JM109, and secondary screening
or false positives performed by transformation of these isolated
ibrary plasmids into S. cerevisiaeAH107 containing either pGBKT7-
K1 or empty pGBKT7. Conﬁrmed positives where identiﬁed as
hose enabling yeast growth on SD medium lacking tryptophan,
eucine and histidine only in the presence of pGBKT7-SK1, as well
s enabling expression of -galactosidase.
.2. Generation of CCT mammalian expression construct
The partial CCT sequence isolated from the yeast two-
ybrid screen was analysed via the NCBI database to design
rimers for PCR ampliﬁcation of the full-length CCT
Genbank accession number AF026292). CCT was PCR
mpliﬁed from human foreskin ﬁbroblast cDNA using the
rimers, 5′-TAGAATTCCCATGATGCCCACACCAGT-3′ and 5′-
AGAATTCAGTGGGGGCGGCCACGAC-3′, digested with EcoRI
nd cloned into pCMV(HA) mammalian expression vector (Clon-
ech). The orientation was determined by restriction analysis with
equencing verifying the integrity of the resultant CCT cDNA
ontaining a hemaglutinin (HA) epitope-tag at the n-terminus..3. Cell culture and transfections
Human embryonic kidney cells (HEK293T) and human cervi-
al cancer (HeLa) cells were cultured and transfected as described
f
p
1
5
temistry & Cell Biology 41 (2009) 822–827 823
reviously (Pitson et al., 2000b; Leclercq et al., 2008). Cells were
outinely harvested in 50mM Tris/HCl buffer (pH 7.4) containing
0% glycerol, 0.5% Nonidet P-40, 150mM NaCl, 1mM dithiothreitol,
mM Na3VO4, 10mM NaF, 1mM EDTA and CompleteTM protease
nhibitors (Roche Diagnostics GMbH, Mannheim, Germany). Cell
ysis was enhanced by six passages through a 26gauge needle
nd the lysates then centrifuged at 13,000 g for 10min at 4 ◦C to
emove insoluble material. Protein concentrations of cell lysates
ere determined with Coomassie Brilliant Blue reagent (Sigma)
sing bovine serum albumin as standard.
.4. CCT-1 knock-down by siRNA
siRNA knock-down of CCT was performed in HeLa cells by
ransfection with CCT-1 siRNA duplexes (siRNA-1, 5′-UUUA-
CUCUGCGCAGAGCGACUAUG-3′, and siRNA-2, 5′-UAUCCCAUA-
GCCUACUUCUGCUGC-3′) or control siRNA (Invitrogen) using
iPerFect (Qiagen). The cellswere thencultured for twodays, trans-
ected again with the same siRNAs, and cultured for a further two
ays before harvesting and analysing for CCT-1 levels and sphin-
osine kinase activity.
.5. Pull-down, immunoprecipitation and Western blot analyses
For pull-down analyses recombinant SK1 was generated and
uriﬁed as a glutathione s-transferase (GST)-fusion protein in E. coli
s previously described (Pitson et al., 2000a). This GST-SK1 (1g)
as then bound to glutathione-Sepharose (Amersham), added to
ell lysates and incubated at 4 ◦C for 1h with constant agitation.
CT associated with SK1 was then determined by immunoblot
ith anti-HA antibodies (Sigma) to detect HA epitope tagged
CT. Lysates were probed with GST alone bound to glutathione-
epharose as a control. For immunoprecipitation antibodies were
dded to cell lysates and incubated at 4 ◦C for 3h with constant agi-
ation. The immune complexes were then captured by incubation
ith protein A-Sepharose (Amersham Pharmacia Biotech) for 1h
t 4 ◦C and washed with cold lysis buffer. Following SDS-PAGE and
ransfer of the proteins to nitrocellulose membranes, immunoblots
ere performed using M2 anti-FLAG antibody (Sigma) to detect
LAG epitope tagged SK1 or anti-HA antibodies to detect CCT.
olyclonal goat anti-CCT-1 and rat anti-CCT antibodies were
rom Santa Cruz Biotechnology and Stressgen (Victoria, Canada),
espectively. The immunocomplexes were detected with HRP-
onjugated anti-mouse, -rabbit, -rat, or -goat IgG (Pierce) using
n enhanced chemiluminescence kit (ECL, Amersham Pharmacia
iotech).
.6. Sphingosine kinase assays
Sphingosine kinase activity was determined using d-erythro-
phingosine (Biomol, Plymouth Meeting, PA) and [-32P]ATP as
ubstrates as described previously (Roberts et al., 2004). One unit
U) of activity is deﬁned as 1pmol of S1P formed per minute per
g of protein.
.7. Pulse-chase analysis
HEK293T cells were transfected with either pCMV(HA)-CCT
lone, or co-transfected with pcDNA3-SK1(FLAG) (Pitson et al.,
000a). After 16h the cells were incubated for 1h in methionine-
ree DMEM containing 10% dialysed foetal calf serum, and then
ulse labelled with fresh methionine-free DMEM containing
00Ci/ml [35S]methionine/cysteine (MP Biomedicals, CA) for
min. Cellswere thenwashed and chased for 45min inDMEMcon-
aining 10% foetal calf serum, 20mM unlabelled methionine and
8 f Biochemistry & Cell Biology 41 (2009) 822–827
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Fig. 1. CCT interacts with SK1. (A) GST-SK1 bound to GSH-Sepharose was incu-
bated with lysates from HEK293T cells expressing HA-tagged CCT. CCT pulled
down by the GST-SK1 was detected by immunoblot with anti-HA antibodies. (B)
Lysates from HEK293T cells co-transfected with FLAG-tagged SK1 and HA-tagged
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0mM unlabelled cysteine. Extracts were prepared by lysing cells
n ice in 25mM Tris/HCl buffer (pH 7.4) containing 10% glycerol,
.5% Nonidet P-40, 75mM NaCl, 10mM EDTA, 5mM NaF, 5mM -
lycerophosphate, 1mM Na3VO4 and protease inhibitors. Cell lysis
as enhanced by six passages through a 26gauge needle and the
ysates then centrifuged at 13,000 g for 10min at 4 ◦C to remove
nsoluble material. Clariﬁed cell lysates were then divided and
mmunoprecipitation of CCT and SK1 achieved via their HA and
LAGepitopes, respectively,with immunocomplexes isolated using
rotein A-Sepharose. Co-immunoprecipitation of SK1 and CCT in
he immunocomplexes were then assessed by immunoblot anal-
sis, and 35S-incorporation into the immunoprecipitated proteins
etermined by Phosphorimaging of dried gels following SDS-PAGE.
.8. Yeast CCT studies
A temperature-sensitive CCT (anc2-1 mutant) strain of S. cere-
isiae (DDY299) and its corresponding wildtype strain (DDY186)
ere kindly provided by David Drubin (University of California,
erkeley) (Vinh and Drubin, 1994). Human SK1 cDNA was trans-
ormed into these stains in pGBKT7 with transformants isolated
n yeast SD plates lacking leucine. Cells were then grown in liq-
id SD medium lacking leucine at 25 ◦C, divided, and duplicate
0ml cultures then growth at 25 ◦C and 35 ◦C (permissive and
on-permissive mutant CCT temperatures, respectively) for 8h.
ells were then harvested by centrifugation at 10,000 g for 5min
t 4 ◦C, resuspended in 50mM Tris/HCl buffer (pH 7.4) containing
0% glycerol, 0.5% Nonidet P-40, 150mM NaCl, 1mM dithiothreitol,
mM Na3VO4, 10mM NaF, 1mM EDTA and CompleteTM protease
nhibitors, and following addition of 0.3 g of glass beads (212-
00m; Sigma) lysed by vortexing 3×1min at 2500 rpm. Cell
ysates were then centrifuged at 13,000 g for 10min at 4 ◦C to
emove insoluble material and assayed for total protein and sphin-
osine kinase activity.
. Results and discussion
.1. CCT interacts with SK1
To gain a better understanding of the regulatory mechanisms
ontrolling SK1 function, we performed a yeast two-hybrid screen
o identify proteins that interact with SK1. Human SK1 was used
s bait to screen a human leukocyte cDNA library. One partial
DNA isolated from this screen was of subunit 7 of the chaper-
nin CCT/TRiC complex (CCT), corresponding to the c-terminal
00 amino acids of this 59kDa protein (residues 344–543).
Since yeast two-hybrid screens can generate false positive
esults, putative protein–protein interactions identiﬁed by this
ethodology must be conﬁrmed by other approaches. To do
his full-length CCT cDNA was ampliﬁed from human foreskin
broblast cDNA and cloned into pCMV(HA) mammalian expres-
ion vector. The resultant HA epitope-tagged CCT was then
xpressed in HEK293T cells, and its putative interaction with SK1
nitially assessed via pull-down analysis using puriﬁed recombi-
ant GST-SK1. Consistent with the yeast two-hybrid screen, these
ull-down analyses showed an interaction between CCT and SK1
ince CCT was isolated speciﬁcally with glutathione-Sepharose
oaded with GST-SK1, but not with GST alone (Fig. 1A). The inter-
ction between SK1 and CCT was then further conﬁrmed by
o-immunoprecipitation analysesusing lysates fromHEK293T cells
o-expressingHA-taggedCCT andFLAG-taggedSK1 (Fig. 1B). Con-
istentwith the results of the pull-down experiments, the presence
f SK1 in the anti-HA (CCT) immunocomplexes was observed.
ogether, this data provided considerable evidence supporting the
r
f
b
fCTwere immunoprecipitated (IP) with anti-HA and SK1 present in the immuno-
omplexes detected by immunoblot with anti-FLAG antibodies. IgGH represents the
eavy chain of the anti-HAantibody. Results are representative of three independent
xperiments.
xistence of an interaction between SK1 and CCT in mammalian
ells.
.2. CCT overexpression has no effect on cellular SK1 activity or
ctivation
Aprevious study (Hanafy et al., 2004) suggested that CCT could
nteract with soluble guanylyl cyclase and inhibit its nitric oxide-
ependent activation both in vitro andwhen overexpressed in cells.
ince SK1 is also an enzyme that can be rapidly and transiently
ctivated (Pitson et al., 2003), and its catalytic activity can also be
ffected by interaction with a number of different proteins (Lacana
t al., 2002; Fukuda et al., 2004; Fujita et al., 2004; Maceyka et al.,
004;Urtz et al., 2004;Olivera et al., 2006; Sun et al., 2006; Leclercq
t al., 2008), we examined the possible effects of CCT overex-
ression on basal cellular SK1 activity and its agonist-dependent
ctivation. Unlike the situation with soluble guanylyl cyclase, how-
ver, overexpression of CCT in HEK293T cells had no detectable
ffect on either basal SK1 activity, or SK1 activation induced by cell
reatment with phorbol esters or tumour necrosis factor- (Fig. 2),
wo agonists previously shown to activate this enzyme (Pitson et
l., 2000b).
.3. CCT acts as a SK1 chaperoninCCT is one subunit of the CCT/TRiC complex, a large double
ing-shaped, hexadecameric chaperonin composed of eight dif-
erent subunits (Valpuesta et al., 2002). The CCT/TRiC chaperonin
inds unfolded polypeptides in its central cavity and mediates
olding and release in a Mg2+/ATP-dependent manner (Frydman,
J.R. Zebol et al. / The International Journal of Biochemistry & Cell Biology 41 (2009) 822–827 825
Fig. 2. CCT overexpression has no effect on cellular SK1 activity or activation.
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Fig. 4. TRiC/CCT associates with newly translated SK1. HEK293T cells co-
transfected with FLAG-tagged SK1 and HA-tagged CCT were pulse-labelled with
[35S]methionine/cysteine for 5min (P), chased for 45min (C), then harvested, lysed
and immunoprecipitatedwith either anti-HA (for CCT) or anti-FLAG (for SK1) anti-
bodies. Phosphorimager analysis of the immune complexes after SDS-PAGE showed
the presence of 35S-labelled proteins in the CCT immunoprecipitates during the
pulse and not chase phases indicating that TRiC/CCT associates with newly trans-
l
b
e
p
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w
(EK293Tcells overexpressingCCT (ﬁlledbars)were left untreated (Nil), or exposed
o TNF (1ng/ml) for 10min or PMA (100ng/ml) for 30min and then harvested and
nalysed for endogenous SK activity, and compared to empty vector transfected cells
open bars). Data is mean± S.D. of three independent experiments.
001). To investigate the possible interaction of the intact CCT/TRiC
omplex with SK1 we initially examined the presence of other
CT/TRiC subunits inpull-downanalyseswithGST-SK1 fromlysates
f untransfected HEK293T cells. In addition to CCT, both CCT
nd CCT subunits were also found to speciﬁcally associate with
K1 (Fig. 3A) suggesting that these observed interactions may be
s a result of the intact chaperonin CCT/TRiC complex associat-
ng with SK1. To examine this possibility further we examined the
g2+/ATP dependence of the interaction between CCT and SK1
ince the action and subsequent dissociation of functional chap-
ronins from their substrates has an absolute requirement on this
ucleotide (Spiess et al., 2004). Consistent with the potential role
ig. 3. The TRiC/CCT chaperonin complex interacts with SK1. (A) GST-SK1 bound
o GSH-Sepharose was incubated with lysates from HEK293T cells expressing HA-
agged CCT. The presence of TRiC/CCT subunits in these GST-SK1 pull-downs were
etectedby immunoblottingwith anti-CCT, anti-CCT andanti-HA (for CCT) anti-
odies. (B) The ATP-dependence of the SK1–CCT interaction was assessed using
ysates from HEK293T cells transfected with HA-tagged CCT that were subjected
o the same pull-down analysis, but performed in the presence of either 5mM ATP
r 5mM EDTA to chelate Mg2+ and thus reduce available Mg2+/ATP. Results are
epresentative of more than three independent experiments.
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bated SK1. The presence of CCT and SK1 in the immune complexes was conﬁrmed
y immunoblot analysis, while anti-FLAG immunoprecipitations demonstrated that
qual 35S-labelled SK1 was present in the cells harvested after the pulse and chase
hases. Results are representative of three independent experiments.
f CCT/TRiC as a SK1 chaperonin, the association of CCTwith SK1
as found to be markedly decreased in the presence of Mg2+/ATP
Fig. 3B).
.4. CCT interacts with newly synthesized SK1 and is necessary
or SK1 maturation
The CCT/TRiC chaperonin appears to have a primary cellular
unction of folding some newly translated polypeptides. While
ubulin and actin folding appear to constitute the predominant
ctivity of CCT/TRiC (Siegers et al., 2003), this chaperonin is also
nvolved in the folding of a distinct set of other cellular, non-
ytoskeletal proteins (Thulasiraman et al., 1999; Camasses et al.,
003; Spiess et al., 2004;Dekker et al., 2008). Todeterminewhether
CT/TRiC may be required for SK1 folding, we initially examined
he timing of CCT interaction with SK1 in a pulse chase experi-
ent (Fig. 4).Newly translatedSK1was foundassociatedwithCCT
ut was released during the subsequent chase, consistent with a
ossible role of CCT/TRiC in folding of newly translated SK1.
The CCT/TRiC chaperonin is highly conserved amongst eukary-
tic species fromyeast to humans (Valpuesta et al., 2002). Thus, the
east S. cerevisiae, where a mutant possessing a temperature sensi-
ive variant of CCT4 (CCT) that inactivates the function of the yeast
CT chaperonin has been characterised (Vinh and Drubin, 1994;
himon et al., 2008), provided a useful system to initially exam-
ne the role of CCT/TRiC in folding and maturation of SK1. Human
K1 was expressed in both wildtype and the temperature sensitive
CT mutant of S. cerevisiae, the yeast grown at the permissive and
on-permissive temperatures (25 ◦Cand35 ◦C, respectively) for 8h,
arvested and sphingosine kinase activity in the yeast cell lysates
etermined (Fig. 5). Consistentwith a role of CCT in SK1maturation,
blation of yeast CCT function by incubation of the temperature
ensitive CCT mutant at the non-permissive temperature lead to a
ubstantial decrease in SK1 activity that was not observed in the
ildtype yeast.
To further examine the role of the CCT/TRiC chaperonin in
K1 folding and maturation in human cells we employed a siRNA
pproach to knock-down levels of CCT-1. This, in turn, has been
reviously shown to decrease the cellular levels of the other mem-
ers of the CCT/TRiC complex and attenuate folding and function
826 J.R. Zebol et al. / The International Journal of Bioch
Fig. 5. Use of temperature-sensitive CCT mutant yeast indicates a role for CCT in
SK1 function. Human SK1 was constitutively expressed in a temperature-sensitive
CCT strain of S. cerevisiae and its corresponding wildtype strain. Control yeast
strains were transduced with the empty vector. The yeast cultures were initially
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rrown at 25 ◦C, and then incubated for 8h at 25 ◦C (open bars) and 35 ◦C (ﬁlled bars)
hich represented the permissive and non-permissive mutant CCT temperatures,
espectively. Cells were then harvested, lysed and assayed for total SK activity. SK
ctivity in vector control cells represents endogenous yeast SK.
f substrate proteins (Kunisawa and Shastri, 2003; Grantham et al.,
006). Knock-down of CCT-1 in HeLa cells lead to a substantial
ecrease in cellular sphingosine kinase activity (Fig. 6). Although
hese cells still retained some active SK1, possibly due to both the
resence of residual CCT/TRiC and the stability of SK1 (Kihara et al.,
006), these results were, again, consistent with an important role
f CCT/TRiC in SK1 maturation.
.5. Conclusions and implications of this study
A substantial fraction of newly synthesized polypeptides appear
o fold spontaneously in the cell (Frydman, 2001). Folding of the
emaining proteins is achieved via molecular chaperones, of which
wo main systems exist in eukaryotes: the heat shock protein (hsp)
0/hsp40system,andCCT/TRiCchaperonin (Frydman,2001). In this
tudywehave presented data that supports an essential role for the
CT/TRiC chaperonin in folding andmaturation of newly translated
K1.
A number of CCT/TRiC substrates have been identiﬁed (Ho et al.,
002; Gavin et al., 2002; Spiess et al., 2004; Dekker et al., 2008),
ncluding cytoskeletal proteins such as actin and tubulin, and sig-
ig. 6. siRNA-mediated knock-downof CCT decreases endogenous SK1 activity. (A)
iRNAs directed against CCT-1 were transfected into HeLa cells and the decrease in
he overall level of CCT-1 protein determined in the cell lysates by immunoblot
ith anti-CCT antibodies. Immunoblots for ERK1/2 were used as loading con-
rols. Densitometry revealed an approximate 70% knockdown in CCT-1 levels. (B)
ysates from HeLa cells transfected with CCT-1 siRNA (CCT siRNA) or control siRNA
ctl siRNA) were analysed for endogenous SK activity. Data is mean± S.D. for three
ndependent experiments. Data shown is for CCT-1 siRNA-1, with similar results
bserved for siRNA-2 (data not shown).
a
A
S
M
R
C
C
D
D
D
F
Femistry & Cell Biology 41 (2009) 822–827
allingproteins suchasCdc20 (Camasses et al., 2003), cyclinE (Won
t al., 1998), polo-like kinase 1 (Plk1) (Liu et al., 2005), HIF pro-
yl hydroxylase PHD3 (Masson et al., 2004), G-transducin (Farr et
l., 1997), and von Hippel-Lindau tumour suppressor protein (VHL)
Feldman et al., 1999). Indeed, CCT/TRiC appears to be involved
n maturation of a diverse but distinct subset of cellular proteins,
hich although estimated in one study to be up to 15% of newly
ynthesised polypeptides (Thulasiraman et al., 1999), this ﬁgure
ncluded the highly abundant substrates actin and tubulin which
ay consume 50–60% of cellular CCT/TRiC activity (Siegers et al.,
003). Most CCT/TRiC substrates appear to be between 30 and
0kDa (Thulasiraman et al., 1999), and be either prone to aggre-
ation or components of oligomeric complexes (Dunn et al., 2001;
piess et al., 2004). In this light, SK1 could be considered a typical
CT/TRiC substrate since it is an aggregation-prone 43kDa pro-
ein (Pitson et al., 2000a). Indeed, we have observed that diverse
oint mutations and short deletions render SK1 unfolded and cat-
lytically inactive (Pitson et al., 2002). Once folded, however, SK1
s relatively stable to heat and pH (Pitson et al., 2000a). Notably,
K1 interacts with membranes (Pitson et al., 2005), and with a
ydrophobic substrate. The sensitivity of SK1 to folding pertur-
ations, and the participation of CCT/TRiC, may reﬂect a folding
athway that must avoid aberrant interactions between hydropho-
ic domains. In addition, while catalytically active as a monomer,
K1 is known to form stable complexes in cells with a number of
ther proteins that appear to regulate its catalytic activity and cel-
ular localisation (Olivera et al., 2006; Sun et al., 2006; Leclercq et
l., 2008). Notably, CCT/TRiC has been proposed to play a role in
he formation of functional multiprotein complexes, including the
HL-elongin B/C complex (Feldman et al., 1999), cdc20-anaphase
romotingcomplex (Camasseset al., 2003), andGprotein-dimer
ormation (Wells et al., 2006). Thus, it is tempting to speculate that
CT/TRiC may play a role in the regulation of SK1 via facilitating
nteraction with regulatory proteins such as eEF1A (Leclercq et al.,
008), TRAF2 (Xia et al., 2002) or Lyn and Fyn tyrosine kinases
Olivera et al., 2006; Sun et al., 2006).
In conclusion, the data presented in this study suggests that
K1 is a CCT/TRiC substrate. This chaperonin appears to facilitate
olding of newly translated SK1 into its mature active form, which
epresents another level of regulation of cellular SK1 levels and
ctivity.
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